For the quarter ending 2025-09-30, TNGX has $210,136K in assets. $50,105K in debts. $58,338K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 58,338 | 39,272 | ||
| Marketable securities | 94,473 | 141,513 | ||
| Restricted cash | 428 | 428 | ||
| Prepaid expenses and other current assets | 10,540 | 8,887 | ||
| Total current assets | 163,779 | 190,100 | ||
| Property, plant and equipment, gross | 17,406 | - | ||
| Less accumulated depreciation | 10,060 | - | ||
| Property and equipment, net | 7,346 | 7,786 | ||
| Operating leaseright-of-useassets | 36,582 | 37,555 | ||
| Restricted cash, net of current portion | 2,139 | 2,139 | ||
| Other assets | 290 | 310 | ||
| Total assets | 210,136 | 237,890 | ||
| Accounts payable | 2,229 | 2,607 | ||
| Accrued expenses and other current liabilities | 13,113 | 11,510 | ||
| Operating lease liabilities | 3,102 | 2,534 | ||
| Deferred revenue | 0 | 23,374 | ||
| Total current liabilities | 18,444 | 40,025 | ||
| Operating lease liabilities, net of current portion | 31,661 | 32,474 | ||
| Deferred revenue, net of current portion | 0 | 30,437 | ||
| Total liabilities | 50,105 | 102,936 | ||
| Common stock, 0.001 par value 400,000,000 and 200,000,000 shares authorized at september 30, 2025 and december 31, 2024, respectively 111,567,062 and 107,729,343 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 112 | 111 | ||
| Additionalpaid-incapital | 724,201 | 715,036 | ||
| Accumulated other comprehensive income | 121 | 94 | ||
| Accumulated deficit | -564,403 | -580,287 | ||
| Total stockholders' equity | 160,031 | 134,954 | ||
| Total liabilities and stockholders' equity | 210,136 | 237,890 | ||
Tango Therapeutics, Inc. (TNGX)
Tango Therapeutics, Inc. (TNGX)